Strategic partnerships Emery Pharma has a track record of collaboration with biotech and vaccine developers (Centivax, Centi-Flu) and CROs, indicating a strong opportunity to pursue new alliances with emerging biotech firms and clinical program sponsors seeking GLP/CGMP analytical and bioanalytical capabilities.

Clinical program support With capabilities spanning preclinical to Phase 3, and expertise in bioanalytical methods, medicinal chemistry, and analytics, there is a clear upsell path to sponsors requiring end-to-end CRO support across multiple stages of development.

Regulatory credibility FDA registration, DEA licensing, and cGMP/GLP compliance position Emery Pharma as a reliable partner for regulated testing, appealing to organizations prioritizing compliance in outsourced testing and method validation.

Analytical breadth Comprehensive lab capabilities including LC-MS/MS, NMR, HPLC, GC-MS, microbiology, and bioanalytical services enable cross-disciplinary testing for clients needing integrated analytical solutions and method transfer across programs.

Geographic reach Located in the San Francisco Bay Area with a global client base, Emery Pharma can target biotech clusters and vaccine/therapeutics developers both locally and internationally, leveraging proximity for collaborations and rapid project start-ups.